A Human CD34(+) Subset Resides in Lymph Nodes and Differentiates into CD56brightNatural Killer Cells-Reference-Cited by-同舟云学术

A Human CD34(+) Subset Resides in Lymph Nodes and Differentiates into CD56brightNatural Killer Cells

Published:2005-03 Issue:3 Volume:22 Page:295-304
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Freud Aharon G.,Becknell Brian,Roychowdhury Sameek,Mao Hsiaoyin C.,Ferketich Amy K.,Nuovo Gerard J.,Hughes Tiffany L.,Marburger Trent B.,Sung John,Baiocchi Robert A.,Guimond Martin,Caligiuri Michael A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference42 articles.

1. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice;Alimzhanov;Proc. Natl. Acad. Sci. USA,1997

2. IL-15-mediated induction of LFA-1 is a late step required for cytotoxic differentiation of human NK cells from CD34+Lin- bone marrow cells;Barao;J. Immunol.,2003

3. Innate pathways that control acquired immunity;Bendelac;Curr. Opin. Immunol.,1997

4. Definition of a natural killer NKR-P1A+/CD56−/CD16− functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12;Bennett;J. Exp. Med.,1996

5. Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells;Blom;J. Exp. Med.,2000

Cited by 315 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity;Biomedicines;2024-07-25

2. Building a human lung from pluripotent stem cells to model respiratory viral infections;Respiratory Research;2024-07-15

3. A new model of human lymphopoiesis across development and aging;Trends in Immunology;2024-07

4. Transcriptomic diversity of innate lymphoid cells in human lymph nodes compared to BM and spleen;Communications Biology;2024-06-25

5. Bioinformatic Analysis of the Significance of the KIR2DL4 Gene in Recurrent Implantation Failure;Biochemical Genetics;2024-06-10